Data for Q6W dosing of natalizumab SC

Are there data available on every 6-week dosing of subcutaneous natalizumab? Learn about the NOVA study, which was recently amended to obtain data on every 6-week dosing of subcutaneous versus every 6-week dosing of intravenous natalizumab.

Biogen-107547.
Date of preparation: June 2021.